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ABSTRACTA
CBACKGROUND AND PURPOSE: The coming years could be
a watershed period for children and health care as the nation
implements the most significant federal health care legislation
in 50 years: the Accountable Care Act (ACA). A year earlier,
the American Recovery and Reinvestment Act (ARRA) set up
a framework and road map for the eventual universal adoption
of health information technology in its Health Information
Technology for Economic and Clinical Health (HITECH)
provisions, and the Children’s Health Insurance Program Reau-
thorization Act (CHIPRA) legislation articulated a new and
compelling vision for quality measurement in child health
services. Each of these landmark advances in federal health
policy contains relevant provisions for the measurement and
improvement of the performance of the health system. Less
clear is the extent to which the child specific framework articu-
lated in CHIPRAwill be preserved and built upon. Here, we set
forth recommendations for ensuring that measurement and re-
porting efforts under CHIPRA, ARRA, and ACA are aligned
for children.
POLICY THEMES AND RECOMMENDATIONS: Our findings
around problems and recommendations are grouped into 2
broad areas: those that deal with helping states report and useCADEMIC PEDIATRICS
opyright ª 2011 by Academic Pediatric Association S77current measures, and those that deal with expanding the current
measures. Recommendations include 5 aimed at focusing
efforts on measure reporting and use: 1) help states build
a measurement infrastructure; 2) provide specific technical
assistance and support to states on how to collect, report, and
use measures; 3) establish a national office for quality moni-
toring; 4) make available nationally data from states; and 5)
ensure specific focus on child health in HITECH initiatives.
Recommendations also include 3 aimed at extending what is
being measured: 1) continue emphasis on insurance stability;
2) ensure that disparities can be measured and monitored; and
3) build measures that focus on system accountability and
outcomes.
CONCLUSIONS: National health care reform provides the
opportunity to extend coverage and dramatically restructure
systems of care. It will be important to ensure that focus on
health care quality for children be maintained and that the
advances made under CHIPRA reinforce and are not diluted or
overtaken by broader reform efforts.
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ACADEMIC PEDIATRICS 2011;11:S77–S84THE COMING YEARS are likely to be a watershed period
for children and health care as the nation implements the
most significant federal health care legislation in 50 years.
However, the Accountable Care Act (ACA) of 2010 is not
the only driver of changes in health care delivery. A year
earlier, the Health Information Technology for Economic
and Clinical Health (HITECH) provisions of the American
Recovery and Reinvestment Act (ARRA) set up a frame-
work and road map for the eventual universal adoption of
health information technology, and the Children’s Health
Insurance Program Reauthorization Act (CHIPRA) legis-
lation articulated a new and compelling vision for quality
measurement in child health services. Each of these land-
mark advances in federal health policy contain relevant
provisions related to the measurement and improvement
of the performance of the health system. What is less clear
is the extent to which the child specific framework articu-
lated in CHIPRAwill be preserved and built upon.CHIPRA provisions set the stage for quality measure-
ment, monitoring, and reporting. Soon after its passage,
the Centers for Medicare and Medicaid Services (CMS)
entered into formal agreements with the Agency for
Healthcare Research and Quality (AHRQ) and the Health
Resources and Services Administration to implement the
various provisions. An initial core measurement set pub-
lished by the Department of Health and Human Services
(DHHS)1 set the process of quality monitoring in motion,
and AHRQ’s call for a set of Centers of Excellence under
the Pediatric Quality Measurement Program to focus on
improving existing measures and producing new measures
set the stage for expanding the core measurement set.2 At
the same time, AHRQ has significant existing statutory
authorities with respect to the development of quality
measures. This includes promoting health care quality
improvement by conducting and supporting research that
develops and presents scientific evidence regarding allVolume 11, Number 3S
May–June 2011
S78 FAIRBROTHER AND SIMPSON ACADEMIC PEDIATRICSaspects of health care, including methods for measuring
and strategies for improving quality. In addition, AHRQ’s
role includes the ongoing development, testing, and
dissemination of quality measures, including measures of
health and functional outcomes, and the compilation and
dissemination of health care quality measures developed
in the private and public sector.
This article, like others in this special issue, reflects on
the lessons learned over the last 18 months in identifying
the core set of measures and implementing HITECH provi-
sions in ARRA. It sets forth a set of specific recommenda-
tions for ensuring that measurement and reporting efforts
under CHIPRA, ARRA, and ACA are aligned for children.
Recommendations in this paper build on work conducted
for earlier reports, which included input from over 35
key informants and experts and our observations of the
implementation process to date.3,4BACKGROUND
Taken together, the 3 new pieces of legislation have the
potential to move the quality agenda for children forward
dramatically. A brief summary of the quality provisions
of the 3 laws follows.
CHIPRA
Although states have had to report on quality since the
original CHIP legislation in 1997, earlier requirements
were vague and resulted in wide variation in state
approaches and few comparable measures across states.5
The 2009 CHIPRA law represented the first time that
consistent quality measurement and reporting had beenTable 1. CHIPRA Provisions Concerning Measuring and Reporting on
Provisions Strengthening Quality of Care and Health Outcomes
Developing an initial core set of health
care quality measures
By January 1, 2010, the Secr
health quality measures for
duration of children’s cover
and treatments.
Establishing a pediatric quality
measurement program
By January 1, 2011, the Secre
pediatric quality measures
pediatric measures and wil
Measure use and reporting
related requirements
By February 4, 2011, the Sec
procedures and approache
voluntarily report informatio
information to states regard
reporting on the quality of h
Demonstration projects CHIPRA includes $20 million a
10 states and child health p
the use of health information
$25 million for a childhood
Development of a model electronic
health record
The law requires DHHS by Jan
a model electronic health re
Duration of Coverage Also Part of Quality Measurement
CHIP enrollment reports The law requires states to inclu
efforts, including data on co
renewal stages, and childre
Medicaid and CHIP enrollm
plans a description of state
*Adapted from Simpson L, Fairbrother G, Touschner J, Jocelyn G. Im
Reauthorization Act of 2009. New York, NY: Commonwealth Fund; 2009
Act; DHHS ¼ Department of Health and Human Services; CHIP ¼ Childa centerpiece of Medicaid or CHIP legislation.3 Impor-
tantly, CHIPRA established that these provisions apply to
both Medicaid and CHIP, and although reporting is volun-
tary and not mandatory, the provisions make a significant
move toward a consistent strategy across the programs
nationally and at the state level. The quality provisions in
CHIPRA include not only measurement development (a
core set and establishment of a subsequent measurement
program to enhance the core), but also provisions around
guidance for reporting performance by the states and
demonstration programs to showcase and test child quality
measures and promote their use (Table 1). These were
awarded in early 2010, and 7 of the 10 awards (covering
18 states) include a focus on the use of the core measure-
ment set released earlier that year by DHHS. CHIPRA
also contains a provision and funding ($5 million) for
development of a model pediatric electronic health record
format to support quality reporting. Finally, the CHIPRA
provisions recognized that coverage stability is integrally
linked to program performance overall, and that enrollment
and retention of eligible children is an aspect of quality.
Thus, states are now required to report on eligibility criteria,
enrollment, retention, use of simplification measures, and
access to care.
QUALITY PROVISIONS IN HEALTH REFORM LEGISLATION
The ACA contains several quality related provisions—
one count found over 563 references to quality. Noteworthy
aspects of these provisions include a focus on all popula-
tions across ages and types of insurance coverage. The
ACA includes 5 sections addressing quality: develop an
explicit national effort to establish a national strategy forQuality*
etary of DHHS will identify an initial recommended core set of child
use by state programs. The measures include, but are not limited, to
age over a 12-month period, and a wide range of preventive services
tary must establish an ongoing program that advances and improves
for all children. This program will expand upon and increase existing
l award grants for developing and testing pediatric quality measures.
retary will develop a standardized format for reporting information and
s that encourage states to use the initial core measurement set to
n on quality of pediatric programs. The Secretary will also disseminate
ing best practices among states with respect to measuring and
ealth care for children.
nnually for demonstration projects. DHHS will provide grants to up to
roviders to use and test child health quality measures and to promote
technology for children. The law also includes a separate allocation of
obesity demonstration project.
uary 1, 2010, to establish a program to encourage the development of
cord format for children in Medicaid and CHIP.
de in their annual reports data to help assess enrollment and retention
ntinuity of coverage, denials of eligibility at both the application and
n’s access to care. It also requires states to provide more timely
ent data to the Secretary of DHHS and to include in their CHIP state
activities to reduce administrative barriers to enrollment and renewals.
plementation Choices for the Children’s Health Insurance Program
. CHIPRA ¼ Children’s Health Insurance Program Reauthorization
ren’s Health Insurance Program.
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group to advance quality efforts at the national level;
develop a comprehensive repertoire of quality measures;
formalize processes for quality measure selection, endorse-
ment, data collection; and publicly report quality informa-
tion through the work of a consensus-based organization.
Although the strategic plan and priorities do not focus
specifically on children, the legislation specifies that the
priorities identified have the greatest potential for
improving the health care for all populations, including
children and vulnerable populations.6 The health reform
legislation also includes provisions for quality measure-
ment development and calls on the secretary to report on
gaps where no quality measures exist and where existing
quality measures need improvement, updating, or expan-
sion, consistent with the national strategy. Thus, the provi-
sions in health reform actually adopt a similar approach to
measurement to those in CHIPRA. In fact, the exact
language of the bill specifying the quality measurement
program for adults in Medicaid states: “The Secretary shall
identify and publish a recommended core set of adult
health quality measures for Medicaid eligible adults in
the same manner as the Secretary identifies and publishes
a core set of child health quality measures.” Finally, 2 other
provisions also hold potential for improving the quality of
children’s health care: those related to the new Center for
Medicare and Medicaid Innovation with $10 billion over
10 years to test new models of care delivery, and the
Medicaid and CHIP Payment and Access Commission
charged with reporting and advising on payment, access,
and quality under Medicaid and CHIP.HEALTH INFORMATION TECHNOLOGY IN CHIPRA
AND HITECH PROVISIONS OF ARRA
Health information technology includes not only elec-
tronic health records (EHRs), but also patient health records
and health information exchanges. The $19 billion invest-
ment in the HITECH provisions of ARRA to promote the
meaningful use of EHRs by both hospital and ambulatory
providers greatly enhances the potential of the smaller ($5
million) CHIPRA investment. In addition to the funds
provided as direct financial incentives to promote adoption,
this legislation also establishes health information tech-
nology policy and standards committees and earmarks $2
billion for DHHS to support adoption through grants,
a national resource center, a network of regional resource
centers, and an extension program. All of these have the
potential to dramatically improve the use of EHRs by child
health providers, if attention to child needs is assured in
DHHS’s implementation of these new funds. It is important
to note that the HITECH provisions in ARRA are actually
surprising in their focus not just on technology, but also
on improving health care quality and outcomes through
the use of these technologies. Therefore, payments are not
direct reimbursements for EHRs but instead are intended
to serve as incentives to adopt and meaningfully use certi-
fied EHR technology. It is the “meaningful use” language,
along with incentive payments, that focuses theseprovisions on quality. By summer 2010, DHHS had
awarded under the HITECH provisions: $548 million to
56 states and territories to promote health information
exchanges, $642 million to 60 regional extension centers
in 46 states, $250 million to 17 beacon communities, and
over $80 million in workforce development grants.7FINDINGS AND RECOMMENDATIONS
FOR IMPLEMENTATION
CMS and AHRQ have moved swiftly to implement the
CHIPRA provisions, including those on quality, despite
gaps in leadership at CMS and the intense efforts on health
reform. Key among these efforts was the establishment of
a Subcommittee of the National Advisory Council for
Healthcare Research and Quality (SNAC), whose role
was as follows: provide guidance on criteria for identifying
an initial core measurement set, provide guidance on
a strategy for gathering additional measures, and review
and apply criteria to a compilation of measures to begin se-
lecting the initial core measurement set. SNAC’s work is
described in the report that accompanied the publication
of recommendations in the Federal Register.8 Final
measures are listed in Table 2. At the same time, the Office
of the National Coordinator, which was set up to
implement the HITECH provisions, has awarded over
$50 billion in funds to states and organizations for
promoting health information technology adoption and
use and has promulgated criteria for meaningful use and
the conditions under which providers and hospitals may
receive incentive payments.9 Several findings and atten-
dant recommendations emerged from interviews with
experts and from our own analysis about implementation
choices to date. These describe current problems and set
forth steps needed to ensure that quality monitoring provi-
sions under CHIPRA—and ultimately ACA and the
HITECH provisions of ARRA—are implemented in
a way that enables states to collect, report on, and use the
data, as well as steps needed to create uniform reporting
that will lead to a national picture of child health quality.
Our findings around problems and recommendations are
grouped into 2 broad areas: those that deal with helping
states report and use current measures (Table 2), and
those that deal with expanding the current measures.
Many of the recommendations require funding. It is
crucially important to recognize that states will be seeking
to develop capacity to monitor quality as called for in CHI-
PRA in the context of highly constrained state budgets.
Economic conditions continued to worsen through 2010:
state budget shortfalls are occurring as public coverage
rolls are rising; thus, more funds are needed to serve the
eligible uninsured. Indeed, as one expert commented,
“fiscal issues are overwhelming all programmatic deci-
sions.” Where possible, our recommendations indicate
sources of funding for the states.
FOCUS EFFORTS ON REPORTING AND USE
Despite the fact that CHIPRA is a first in terms of quality
provisions in federal statute, most states have engaged in
Table 2. Recommended Initial CoreMeasures for Children’s Health
Care Quality*
Prevention and Health Promotion
Prenatal/perinatal
B Frequency of ongoing prenatal care (NCQA measure)
B Timeliness of prenatal care (NCQA measure)
B Percentage of live births weighing <2500 g
B Cesarean rate for low-risk first birth women
Immunizations
B Childhood immunization status (NCQA measure)
B Adolescent immunization (NCQA revised for 2010)
Screening
B Body mass index documentation in 2–18-year-olds
B Rates of screening for delays using screening tools
B Chlamydia screening for women
Well-child care
B Well-child visits in the first 15 months of life
B Well-child visits in years 3 through 6 of life
B Well-child visits for 12–21 years of age—with PCP
Dental
B Total eligibles receiving preventative dental care
Mangement of Acute Conditions
B Pharyngitis—appropriate testing (NCQA measures)
B Otitis media effusion—avoidance of inappropriate use
B Total EPSDT eligibles who received dental treatment
B ED utilization—average 3 ED visits per member
B Pediatric catheter-associated bloodstream infection rates (PICU
and NICU)
Mangement of Chronic Conditions
B Annual no. of asthma patients with $1 asthma ED visit
B Follow-up care for children prescribed ADHD medication
B Annual hemoglobin A1C testing
Family Experiences of Care
B CAHPS Health Plan Survey 4.0, Child Version
Availability of Services
B Children and adolescents access to PCP
*NCQA ¼ National Committee for Quality Assurance; PCP ¼
primary care physician; EPSDT ¼ Early Periodic Screening, Diag-
nosis, and Treatment; ED ¼ emergency department; PICU ¼ pedi-
atric intensive care unit; NICU ¼ neonatal intensive care unit;
CAHPS ¼ Consumer Assessment of Healthcare Providers and
Systems; ADHD ¼ attention-deficit/hyperactivity disorder.
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ready to push forward in the directions indicated by
CHIPRA.10 However, state quality monitoring efforts are
not uniform, need to be more rigorous, and do not capture
the full range of services that children need. Implementing
CHIPRA involves more than implementing specific provi-
sions, but rather also involves new roles, relationships, and
partnerships between DHHS and the states—roles that
ideally should carry over into the implementation of health
reform legislation. To ensure that CHIPRA achieves the
full impact of its landmark provisions and to ensure these
are preserved under ACA, actions at the federal and state
levels are needed to build capacity for states to fully
develop, sustain, and spread meaningful measurement,
improvement, and accountability approaches. CHIPRA is
an opportunity to recalibrate the partnership between states
and DHHS, in particular CMS. Specific steps the federal
agencies could take are outlined below.
HELP STATES BUILD A MEASUREMENT INFRASTRUCTURE
States will need strong capabilities to collect, store, and
analyze data, including obtaining quality of care measuresfrom claims in the short term, and later from EHRs and
health information exchanges—the latter as a source of
data for quality measures, especially for topics such as
coordination of care across settings.
Having sophisticated data warehousing and linking
capabilities, as well as abilities to exchange data, are
fundamental building blocks for quality measurement.
Some states have this capability. For example, 10 or
more states have all-payer claims databases, which they
are using to answer question about cost and quality of
care.11 As another example, New York collects member-
level data reported by Medicaid managed care plans (for
all members) as part of annual Healthcare Effectiveness
Data and Information Set (HEDIS) reporting and has
created linkages of quality measurement results with eligi-
bility files and Consumer Assessment of Healthcare
Providers and Systems (CAHPS) surveys, as well as lead
and immunization registries. Data sets such as these enable
states to monitor care over time and across settings.
However, these states are the exception, not the rule.
Such capability will be necessary for robust monitoring
of quality. Although technical assistance to states will be
critical to helping move this forward, actual additional
investments of staff, hardware, and software by states
and CMS will also be needed. Thus, CMS should expand
its ability to provide technical support in the development
of data infrastructure that will support quality measure-
ment as well as directly fund states. The most appropriate
mechanism for the latter might be expanding the types of
state data investments that are eligible for an enhanced
federal matching rate of 90%, rather than the usual 50%
match for administration. (Medicaid reimburses expan-
sions of health information technology programs at a rate
of 90% to encourage use of certified EHRs and electronic
exchange of health information.12)
PROVIDE SPECIFIC TECHNICAL ASSISTANCE
AND SUPPORT TO STATES ON HOW TO COLLECT,
REPORT, AND USE MEASURES
It will not be enough to simply provide measures. States
will need more specifications and technical assistance to
measure and report on all populations. Currently, states
generally measure quality for managed care populations,
usually through the HEDIS process, and to some extent
for children under primary care case management.
CHIPRA calls for measuring for all Medicaid and CHIP
children, which would include those in fee-for-service
Medicaid as well as managed care and primary care case
management. Guidance will be needed on how to respecify
measures for all populations, as noted by SNAC.8 For
example, currently health plans report on children who
have been in the plan continuously for a specified amount
of time, which varies by the measure, but is generally at
least 11 out of 12 months. Under CHIPRA, the continuous
enrollment standard will shift to Medicaid and CHIP. This
maymean that childrenwould need to be in public coverage
for the specified amount of time, but not necessarily in the
same plan. Such a shift would signal that Medicaid/CHIP
are the entities held responsible for quality improvement.
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data. For example, should states report data separately by
delivery system as listed above or combined? Or how
should the various populations within Medicaid be re-
ported (eg, should the seriously ill children in the aged,
blind, and disabled category be reported separately from
other children in Medicaid? Should children in managed
care be reported separately from those in fee for service?).
Well-thought-out guidance for reporting on Medicaid and
CHIP children should form the foundation for guidance
on reporting on all children under health reform.
However, even after all of these actions are taken,
a number of states, if not most, will simply lack the
capacity to actually collect, analyze, report on, or use the
measures. In some ways, states’ capacity to execute these
responsibilities today are similar to those that states had
in the early 1950s in epidemiology, when the Epidemi-
ology Intelligence Service was established. CMS should
partner with AHRQ to establish a Child Quality Corps
that could train the workforce needed to meaningfully
use measures and make these available to states on 1- or
2-year assignments. This adaptation of the Epidemiology
Intelligence Service model was used in the 1980s when
maternal and child health epidemiologists were made
available to states and other public health agencies and
organizations. An investment of $15 million annually
would be sufficient to establish a national program office,
give recruitment and training support, and provide all 50
states with a trained quality manager capable of expanding
(or initiating) state capacity.
Finally, and perhaps most significantly, assistance will
also be needed to ensure that measures are not just reported
on, but actually used to improve care within states and
communities. A significant shortcoming of the CHIPRA
legislation is that, apart from the demonstration program,
it emphasizes measurement and reporting, not actual
improvement of care or outcomes. The $100 million
demonstrations reach only 18 states—and many of them
were the smaller states and did not encompass all Medicaid
and CHIP children.13 At minimum, this means that states
will need to ensure that relevant data get into the hands
of entities that can bring about improvement—managed
care plans, provider groups, communities, the public,
and possibly providers themselves. Here, the ACA might
be used to directly align and enhance CHIPRA efforts
by ensuring that the $10 billion available in innovation
grants through CMS include child health improvement
demonstrations.
ESTABLISH A NATIONAL OFFICE FOR QUALITY MONITORING
TO SUPPORT THE STATES
Bringing about the quality improvements envisioned by
CHIPRA and health reform legislation requires a sustained
focus from DHHS. A national office for quality monitoring
could be the focal point for guidance and technical assis-
tance to the states and for developing polices for using the
information to improve quality. This will require a signifi-
cant investment in staff and resources nationally—similar
to the investment made in the Medicare program over thepast few decades. Although specific dollar amounts are
hard to identify for this support at the national level, the
DHHS fiscal year 2010 budget proposal does specify in
the ninth scope of work (from 2008–2011) that the budget
for clinical improvement under the quality improvement
organizations in Medicare is approximately $400 million
annually, which represents an investment of about $9 for
each of the 46 million Medicare beneficiaries.14,15 A
similar level of investment for children covered through
Medicaid (29 million children in 2007) and CHIP (4.9
million in 2009) would be $102 million annually. This is
clearly a significant increase over the current $20 million
per year under the CHIPRA demonstrations, but it is still
a small number in terms of per-child investment. This
national office could also design policies to encourage re-
porting by all 50 states and the District of Columbia once
the funding and supports described above are in place.
Achieving national reporting will be crucial because it
provides comparative benchmarks and ensures the national
accountability that CHIPRA seeks to create. Future legisla-
tion could consider making reporting of quality measures
mandatory, just as reporting on CAHPS measures and on
enrollment duration is mandatory. Absent a mandate for
reporting, the support of a national office will be key.
THE DATA THAT SUPPORT THE CORE MEASURES,
NOT JUST AGGREGATE DATA, SHOULD BE MADE
AVAILABLE NATIONALLY
Reports from states aggregated at the state level, or even
at the individual plan level, are of limited usefulness for
policy makers and program managers in understanding
where quality improvement efforts need to be targeted or
for which populations. This recommendation would have
Medicaid moving in the direction of Medicare, where
data are reported by organizations (eg, hospitals, nursing
homes). Data could be put into a national data structure,
such as the Healthcare Cost and Utilization Project
(HCUP) which is a family of data sets sponsored by
Agency for Healthcare Research and Quality, the CAHPS
Benchmarking Database, or even CMS sites such as
Nursing Home Compare, to create a “Child Health
Compare,” comprising the various components of the
data set (eg, hospital data, CAHPS), where queries or
specific prepackaged state reports could be run. Thus, the
information would be available broadly for state programs
and policy makers and deidentified data could be made
available for researchers. The current HCUP budget for
data is just under $2 million annually, but possibly less
would be needed for the proposed approach because the
volume of data would be only the data linked to the core
measures.
LAUNCH A SPECIFIC INITIATIVE TO ENSURE
A FOCUS ON CHILD HEALTH IN ALL OF THE HITECH
AND ACA INITIATIVES
DHHS has the opportunity to ensure that child health
providers in all settings (eg, physician offices, hospitals,
schools, day care facilities) and the needs of children are
systematically addressed by the numerous newly funded
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use provisions for Medicaid providers (ie, those relevant
to children’s health care) afford considerable implementa-
tion flexibility to the states, and that is likely to lead to
substantial variation in the degree to which states are
including the needs of children and child health providers
and systems in their implementation decisions. The Office
of the National Coordinator, in collaboration with CMS
and AHRQ, could establish a specific initiative or focus
across all the HITECH programs and grants to oversee
and coordinate child-specific components and ensure
specific outreach and inclusion of child health issues and
stake holders. Specific examples of areas needing attention
include the degree to which pediatric primary care
providers are opting into the EHR incentive program and
increasing the number of pediatric measures that support
meaningful use. Also needing attention is ensuring that
national and regional extension centers—which were set
up in the HITECH provisions to offer technical assistance,
guidance, and information on best practices to support
health care providers’ efforts to become meaningful users
of EHRs—are including child health providers in their
technical assistance efforts and building capacity in the
national regional extension center program to support
and spread tools, resources, and best practices to all
regional extension centers.EXTEND WHAT IS BEING MEASURED
CONTINUE THE EMPHASIS ON INSURANCE STABILITY
AS AN INTEGRAL ASPECT OF QUALITY
Stable enrollment in theMedicaid and CHIP programs is
an essential first step to ensuring that children have access
to care and to maintaining a focus on quality. Significantly,
although reporting on the core measurement set is volun-
tary, states are mandated to report on the duration of
coverage and on various access dimensions using CAHPS.
In this regard, too, the legislation is a landmark and depar-
ture from the past: for the first time, coverage duration, or
stability, is viewed as an aspect of quality. This relationship
is supported by a body of evidence showing that improved
outcomes occur when children are stably enrolled.16,17
Most uninsured children are eligible for programs but are
not enrolled, and still other reports show high levels of
churning—that is, moving on and off the program.17–20
Also strengthening this relationship, the legislation
includes a number of provisions to improve the enrollment
and retention of eligible children in addition to measure-
ment, including outreach grants to states, bonuses for states
for improved enrollment, and several provisions to simplify
enrollment and renewal to reduce churning.3 The initial set
of core measures did not include a measure of stability,
although this was discussed in planning.21 It will be impor-
tant to develop measures of stability of coverage, to
continue the focus on stability as an aspect of quality, and
to ensure that this provision be seen as strongly linked to
the core measures. There are several approaches that could
be used to do this, including the following: prospective and
retrospective duration measures (following a cohort of newenrollees forward through renewal, or looking backward at
enrollment patterns of a cohort); continuity ratios and
average duration measures (proportion of months enrolled
over all months in the year); retention and disenrollment
rates; and churning rates and turnover in a given year
(percentage of children enrolling and percentage dropping
out in a given year).21 Each of these approaches has pros
and cons that will require investigation.
Finally, the need to focus on stability is only increased
by the ACA and the creation of whole new entities of health
insurance exchanges that will provide coverage to some
children as soon as they are created, and potentially
many more in 2019 when CHIPRA is scheduled to expire.
ENSURE THAT DISPARITIES CAN BE MEASURED
AND MONITORED IN THE QUALITY MEASURES
As with adults, disparities in health status and health
care are pervasive for children, with important and often
lifelong consequences.22,23 Disparities exist on the basis
of race, ethnicity, primary language, special needs, and
geography.24–27 Currently, data do not exist to measure
disparities in many of the data sets. Application forms for
Medicaid and CHIP are a primary source of information
on race, ethnicity, and primary language of the child or
family. Yet these data are collected in various nonstandard
ways by the states, making creating a national picture of
disparities difficult or impossible (author review of
application forms in all states, 2010). Further, race/
ethnicity is missing in over a quarter of the hospital
discharges for children (internal analysis using 2006
Kids’ Inpatient Database). It is not clear how these key
variables are collected in the various EHRs or how
complete the data are. Implementation of CHIPRA is an
opportunity to develop an explicit and standardized
strategy for collecting race, ethnicity, and language
information for all children that cuts across all the
measures, and to align these efforts with work undertaken
in ACA and HITECH. This will then be a platform for
monitoring disparities. This rationalizing of data
collection needs to be followed by an explicit strategy to
ensure that states and the federal government have the
information needed to address disparities. Measurement
of disparities was stressed in AHRQ’s call for new
measure development and in the demonstration
projects.2,13 However, more may be needed at the point of
collection to ensure standardized collection of race,
ethnicity, and language data.
BUILDMEASURES THAT FOCUS ON SYSTEM ACCOUNTABILITY
AND HEALTH OUTCOMES
The initial core set of measures needed to rely largely on
what states were already doing, as explained in the back-
ground paper accompanying the publication of the recom-
mended measures in the Federal Register.8 However,
updates to the measures will not be similarly constrained.
Measures will be updated annually during the period of
the CHIPRA legislation, offering an opportunity to move
into new measures and new topic areas. SNAC noted the
particular need for additional measures in specialty care,
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treatment, as well as measures of coordination of care,
health outcomes, and measures of the medical home.8 A
number of policy bodies and researchers have also identi-
fied gaps in the measures, and an Institute of Medicine
committee is issuing a report summarizing the gaps and rec-
ommending areas for measure development.13,28–32 Our
intent is not to duplicate a list of gaps in specific
measures but rather to point to new overall directions and
capabilities. In the future, for example, if states have the
enhanced capabilities recommended above to collect,
warehouse, link, and report on administrative and health
data, then new possibilities will be opened for monitoring
health care. Furthermore, data will be increasingly
available in an electronic format, allowing for reporting
on outcomes as well as processes.
The fact that data will be available longitudinally in both
cases means that measures can look across time to deter-
mine whether all appropriate aspects of care were deliv-
ered. New measures could take advantage of the new
capabilities by addressing, for example, whether appro-
priate care was provided after a hospitalization (not merely
whether there was a visit), whether all aspects of asthma
care were delivered, or whether an appropriate combina-
tion of drugs was prescribed for a given mental illness.
This capability will enable greater reliance on composite
measures. These composite measures are important
because appropriate care, particularly for chronic condi-
tions, involves more than one service or care at one visit.
Thus, these all-or-none composite measures are needed
to raise the bar on performance.33
In addition, broader measures of care are needed, such as
one that the National Committee for Quality Assurance is
developing to measure not just whether a well-child visit
has taken place, but rather whether all recommended
services have been delivered by the time the child reaches
a specified age.32 Finally, measures need to be adaptable to
changes in organization and delivery of health care. The
emphasis in ACA on system accountability and the need
to ensure adequate value for the expenditures in health
care illustrates this point. CHIPRA’s requirement for
measures of “most integrated health care settings” and
the recommended measure of family experiences of care
could be considered system accountability measures, but
more will be needed.8 The push for accountable care orga-
nizations and a specific state demonstration initiative for
a pediatric accountable care organization will require
some concerted research and testing to determine the
best measures to use in such a financial incentive model.CONCLUSIONS: BEYOND CHIPRA
The progress that is made on quality measurement and
monitoring over the next 4 years through CHIPRA will
serve as the foundation for future efforts across both public
and private sectors. It has already informed the framework
for measurement for adults in Medicaid under ACA and
should continue to inform all measurement related invest-
ments in the coming year, so as to ensure that the progressthat CHIPRA supports is not diluted or overtaken by
broader reform efforts. For this to occur, however, much
more attention is needed to ensure that states have suffi-
cient measurement infrastructure and funding to support
quality monitoring and management and that the federal
government has the capacity to support and guide quality
measurement and improvement efforts. The recent enact-
ment of major health reform has brought the goal of
coverage for all children within reach. Building on and ex-
tending the base established by CHIPRA will help inform
the quality management of a dramatically restructured
system of care.ACKNOWLEDGMENT
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